Article

Segment 8 - Cost of Care and Treatment

The panelists debate the costs of multiple myeloma treatment. There are costs for initial treatment, maintenance care, and the price that comes with taking multiple drugs.

The panelists debate the costs of multiple myeloma treatment. There are costs for initial treatment, maintenance care, and the price that comes with taking multiple drugs. It’s important that treatment is the “best at the beginning.”

In general, the disease is extremely expensive to treat, and there may be nearly 100,000 patients who suffer from the disease. Treatment can last for years, which only adds to costs.

Risk factors are also analyzed by the panel. Dr Kumar notes that some studies have shown African Americans and people who are obese may be at increased risk for developing the disease.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
David Awad, PharmD, BCOP
Coral Omene, MD, PhD, sitting for a vieo interview
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Coral Omene, MD, PhD, sitting for a vieo interview
David Awad, PharmD, BCOP
Screenshot of Coral Omene, MD, PhD
ASCO 2025
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Cathy Eng, MD, FACP, FASCO
Nini Wu, MD, Navista
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo